Electrospray Deposition of PEDOT:PSS on Carbon Yarn Electrodes for Solid-State Flexible Supercapacitors

The increasing demand for flexible electronic devices has risen due to the high interest in electronic textiles (e-textiles). Consequently, the urge to power e-textiles has sparked enormous interest in flexible energy storage devices. One-dimensional (1D) configuration supercapacitors are the most promising technology for textile applications, but often their production involves complex synthesis techniques and expensive materials. This work unveils the use of the novel electrospray deposition (ESD) technique for the deposition of poly(3,4-ethylenedioxythiophene)-poly(styrene sulfonate) (PEDOT:PSS). This deposition methodology on conductive carbon yarns creates flexible electrodes with a high surface area. The deposition conditions of PEDOT:PSS were optimized, and their influence on the electrochemical performance of a 1D symmetric supercapacitor with a cellulose-based gel as an electrolyte and a separator was evaluated. The tests herein reported show that these capacitors exhibited a high specific capacitance of 72 mF g^-1, an excellent cyclability of more than 85% capacitance retention after 1500 cycles, and an outstanding capability of bending.

Spatial and directional characterization of wire and arc additive manufactured aluminum alloy using phased array ultrasonic backscattering method

Pores, grains, or textures can collectively cause microstructural inhomogeneity and anisotropy in metallic materials fabricated by additive manufacturing. In this study, a phased array ultrasonic method is developed to characterize the inhomogeneity and anisotropy of wire and arc additively manufactured components by performing both beams focusing and steering. Two backscattering features, i.e., the integrated backscattering intensity and the root mean square of the backscattering signals, are employed to quantify the microstructural inhomogeneity and anisotropy, respectively. An experimental investigation is performed using an aluminum sample fabricated by wire and arc additive manufacturing. The ultrasonic measurements, performed on wire and arc additive manufactured 2319 aluminum alloy, show that the sample is inhomogeneous and weakly anisotropic. Metallography, electron backscatter diffraction, and X-ray computed tomography are used to verify the ultrasonic results. An ultrasonic scattering model is used to identify the influence of grains on the backscattering coefficient. Compared with a wrought aluminum alloy, the complex microstructure in additively manufactured material significantly influence the backscattering coefficient, and the presence of pores cannot be neglected in ultrasonic-based nondestructive evaluation for wire and arc additive manufactured metals.

Microstructure and mechanical properties of dissimilar NiTi and 304 stainless steel joints produced by ultrasonic welding

Superelastic NiTi alloy and 304 stainless steel (304 SS) were joined with a Cu interlayer by ultrasonic spot welding (USW) using different welding energy inputs. The surface morphology, interfacial microstructure, mechanical properties, and fracture mechanisms of the dissimilar NiTi/304 SS USWed joints were studied. The results showed that the surface oxidation intensified with increasing ultrasonic welding energy due to mutual rubbing between tools and sheets. The weld interface microstructure exhibited voids or unbonded zones at low energy inputs, while an intimate contact was established at the joining interface when applying a higher energy input of 750 J. With increasing energy input to 750 J, the weld interface shows two interfaces due to the behavior of plastic flow of Cu interlayer. The lap-shear load of the joints first increased, achieving a maximum value of ∼690 N at an energy input of 750 J, and then decreased with further increase in welding energy. Interfacial failure was observed at NiTi/Cu interface at all energy inputs, and no intermetallic compounds were found on the fracture surfaces of both the NiTi/Cu and Cu/304 SS interfaces.

Recycling of Reinforced Glass Fibers Waste: Current Status

In this paper, a review of the current status and future perspectives for reinforced glass fiber waste is undertaken, as well as an evaluation of the management hierarchy for these end-of-life materials. Waste levels are expected to increase in the coming years, but an improvement of collection routes is still necessary. The recycling processes for these materials are presented. The associated advantages and disadvantages, as well as the corresponding mechanical characteristics, are described. Although mechanical shredding is currently the most used process, there is a potential for thermal processes to be more competitive than others due to the fiber quality after the recycling process. However, the energy requirements of each of the processes are not yet well explained, which compromises the determination of the economic value of the recycled fibers when included in other products, as well as the process feasibility. Nevertheless, the work of some authors that successfully integrated recycled glass fibers into other elements with increased mechanical properties is evaluated. Future recommendations for the recycling of glass fiber and its commercialization are made.

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus

BACKGROUND

Recent years have witnessed a considerable increase in clinical trials of new investigational agents for Fabry disease (FD). Several trials investigating different agents are currently in progress; however, lack of standardisation results in challenges to interpretation and comparison. To facilitate the standardisation of investigational programs, we have developed a common framework for future clinical trials in FD.

METHODS AND FINDINGS

A broad consensus regarding clinical outcomes and ways to measure them was obtained via the Delphi methodology. 35 FD clinical experts from 4 continents, representing 3389 FD patients, participated in 3 rounds of Delphi procedure. The aim was to reach a consensus regarding clinical trial design, best treatment comparator, clinical outcomes, measurement of those clinical outcomes and inclusion and exclusion criteria. Consensus results of this initiative included: the selection of the adaptative clinical trial as the ideal study design and agalsidase beta as ideal comparator treatment due to its longstanding use in FD. Renal and cardiac outcomes, such as glomerular filtration rate, proteinuria and left ventricular mass index, were prioritised, whereas neurological outcomes including cerebrovascular and white matter lesions were dismissed as a primary or secondary outcome measure. Besides, there was a consensus regarding the importance of patient-related outcomes such as general quality of life, pain, and gastrointestinal symptoms. Also, unity about lysoGb3 and Gb3 tissue deposits as useful surrogate markers of the disease was obtained. The group recognised that cardiac T1 mapping still has potential but requires further development before its widespread introduction in clinical trials. Finally, patients with end-stage renal disease or renal transplant should be excluded unless a particular group for them is created inside the clinical trial.

CONCLUSION

This consensus will help to shape the future of clinical trials in FD. We note that the FDA has, coincidentally, recently published draft guidelines on clinical trials in FD and welcome this contribution.

Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families

Pathogenic mutations in genes COL4A3/COL4A4 are responsible for autosomal Alport syndrome (AS) and thin basement membrane nephropathy (TBMN). We used Sanger sequencing to analyze all exons and splice site regions of COL4A3/COL4A4, in 40 unrelated Portuguese probands with clinical suspicion of AS/TBMN. To assess genotype-phenotype correlations, we compared clinically relevant phenotypes/outcomes between homozygous/compound heterozygous and apparently heterozygous patients. Seventeen novel and four reportedly pathogenic COL4A3/COL4A4 mutations were identified in 62.5% (25/40) of the probands. Regardless of the mutated gene, all patients with ARAS manifested chronic renal failure (CRF) and hearing loss, whereas a minority of the apparently heterozygous patients had CRF or extrarenal symptoms. CRF was diagnosed at a significantly younger age in patients with ARAS. In our families, the occurrence of COL4A3/COL4A4 mutations was higher, while the prevalence of XLAS was lower than expected. Overall, a pathogenic COL4A3/COL4A4/COL4A5 mutation was identified in >50% of patients with fewer than three of the standard diagnostic criteria of AS. With such a population background, simultaneous next-generation sequencing of all three genes may be recommended as the most expedite approach to diagnose collagen IV-related glomerular basement membrane nephropathies.

Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families

Alport syndrome (AS) is caused by pathogenic mutations in the genes encoding α3, α4 or α5 chains of collagen IV (COL4A3/COL4A4/COL4A5), resulting in hematuria, chronic renal failure (CRF), sensorineural hearing loss (SNHL) and ocular abnormalities. Mutations in the X-linked COL4A5 gene have been identified in 85% of the families (XLAS). In this study, 22 of 60 probands (37%) of unrelated Portuguese families, with clinical diagnosis of AS and no evidence of autosomal inheritance, had pathogenic COL4A5 mutations detected by Sanger sequencing and/or multiplex-ligation probe amplification, of which 12 (57%) are novel. Males had more severe and earlier renal and extrarenal complications, but microscopic hematuria was a constant finding irrespective of gender. Nonsense and splice site mutations, as well as small and large deletions, were associated with younger age of onset of SNHL in males, and with higher risk of CRF and SNHL in females. Pathogenic COL4A3 or COL4A4 mutations were subsequently identified in more than half of the families without a pathogenic mutation in COL4A5. The lower than expected prevalence of XLAS in Portuguese families warrants the use of next-generation sequencing for simultaneous COL4A3/COL4A4/COL4A5 analysis, as first-tier approach to the genetic diagnosis of collagen type IV-related nephropathies.

Urban vs. extra-urban environments: scales of variation of intertidal benthic assemblages in north Portugal

Littoral areas are subject to severe and increasing pressures resulting from human activities occurring along or next to the coast. In this study, patterns of variability in the structure of rocky intertidal benthic assemblages and in the abundance of individual taxa were compared between locations close to the coastal cities of Porto and Vila Nova de Gaia (north Portugal) and reference locations far from it in much less urbanized conditions over a temporal scale of fourteen months and multiple spatial scales. Present findings indicated that assemblages were more heterogeneously distributed in the urban than in the extra-urban condition. The total number of taxa and several individual taxa displayed, in general, this same pattern of variability. This could be interpreted as the beginning of a habitat deterioration process with largely unpredictable consequences. The adopted sampling design supports the need for simultaneously including a range of temporal and spatial scales when evaluating responses of coastal marine biodiversity to anthropogenic disturbances.

Immunohistochemical Characterization of 13 Canine Renal Cell Carcinomas

Canine renal cell carcinomas (RCCs) are uncommon aggressive tumors that occur mainly in middle-aged male dogs. Their histologic classification bears no relationship with prognosis, and little information is available concerning their immunohistochemical properties. In this retrospective study, formalin-fixed, paraffin-embedded tissues from 13 canine RCCs were retrieved from the archives, classified histologically, and evaluated immunohistochemically. The dogs were 7 males and 6 females (1 spayed) of 10 different breeds, averaging 8 years in age. The tumors were classified as papillary, tubulopapillary, papillary–cystic, solid, or sarcomatoid. All 13 tumors were immunohistochemically positive for uromodulin, 12 for c-KIT, 11 for vimentin, 9 for wide-spectrum-screening cytokeratins, 7 for cytokeratins AE1/AE3 and carcinoembryonic antigen, 4 for cytokeratins CAM 5.2, and 3 for CD10. All 3 solid RCCs expressed vimentin, c-KIT, and carcinoembryonic antigen and were negative for cytokeratins. All 7 papillary and tubulopapillary tumors expressed vimentin; 6 (86%), cytokeratins; and 6 (86%), c-KIT. Both papillary–cystic RCCs were positive for cytokeratins and c-KIT and negative for vimentin. These results indicate that the different histologic types of RCC have characteristic immunohistochemical profiles and that c-KIT may be involved in the pathogenesis of canine RCC.

The g.1170C>T polymorphism of the 5' untranslated region of the human alpha-galactosidase gene is associated with decreased enzyme expression--evidence from a family study

Subnormal leukocyte α-galactosidase (α-Gal) activity was found during evaluation of an adolescent male with cryptogenic cerebrovascular small-vessel disease. The only molecular abnormality found was the g.1170C>T single-nucleotide polymorphism (SNP) in the 5' untranslated region of exon 1 in the α-Gal gene (GLA). Historically, this polymorphism has been considered to be biologically neutral. To test the hypothesis that the g.1170T allele might be associated with lower α-Gal expression, we genotyped GLA exon 1 and measured leukocyte and plasma α-Gal in the parents, brother and sister of the index case. The g.1170T allele co-segregated with a subnormal leukocyte α-Gal activity in the three siblings. Although plasma enzyme activities were within the normal range in all five relatives, the ranking of their values suggested a dosage effect of the g.1170T allele. Western blotting assays of leukocyte protein extracts showed that the relative expression of α-Gal in both the patient and his sister was significantly lower than in sex-matched hemizygous or homozygous controls for the g.1170C allele, either normalized to the β-actin immunoblot expression or standardized to a known amount of recombinant human α-Gal. These family data, in combination with results from a recent GLA SNP screening study among healthy Portuguese individuals, suggest that the g.1170C>T SNP may be co-dominantly associated with a relatively decreased GLA expression at the transcription and/or translation level. Larger population studies are needed to confirm these findings and to test the hypothesis that the GLA g.1170C>T may contribute to the multifactorial risk of ischaemic small-vessel cerebrovascular disease.

Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human α-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians

BACKGROUND

The α-galactosidase gene (GLA) has three single-nucleotide polymorphisms in the 5' untranslated region of exon 1, respectively g.1150G>A, g.1168G>A, g.1170C>T. The g.1150A allele is associated with increased plasma α-galactosidase (α-Gal) activity in hemizygotes, while the others are regarded as biologically neutral. The primary goal of this investigation was to test the hypothesis, raised by a clinical observation and results of a family study, that the g.1170T allele polymorphism is associated with lower α-Gal expression.

SUBJECTS AND METHODS

Plasma and leukocyte α-Gal activities were assayed in unrelated healthy young adults of both sexes, who had been genotyped for GLA exon 1, and enzyme activity values in carriers of any of the polymorphisms were compared to those of individuals with the standard genotype; GLA exon 1 was genotyped in males who had α-Gal activity in dried blood spots lower than 2 SD below the cohort average.

RESULTS AND CONCLUSIONS

Mean α-Gal leukocyte activity was ∼ 25% higher in subjects with the g.1170C or CC genotype than in those with the alternative genotypes (p < 0.05). The frequency of the g.1170T allele in subjects with low α-Gal activity in dried blood spots was 4-fold higher (p < 0.05) than in the general population. As in hemizygotes, the g.1150A heterozygote identified in this study had plasma α-Gal activity more than 2-fold above the normal mean. The g.1168A allele did not affect enzyme activity. Surprisingly, females with the standard GLA exon 1 genotype had significantly higher plasma α-Gal activity than genetically comparable males.

[Zoonotic brucellosis risk associated with clandestine slaughtered porks]

To determine the sanitary risk to human health, 59 sera samples of clandestine slaughtered porks were examined through serologic procedures and have demonstrated to have anti-Brucella antibodies and antibodies titles suggestive of brucellosis infection. Surveillance measurements are recommended to prevent potential risk of zoonotic infection.

Eggplant (Solanum melongena) infusion has a modest and transitory effect on hypercholesterolemic subjects

Eggplant (Solanum melongena) is consumed extensively in Brazil. It has been believed that infusion of a powdered preparation of the fruit may reduce serum cholesterol. However, there are few documented reports on its effects on cholesterol metabolism and its possible hypocholesterolemic effect has not been proved by well-controlled studies. The aim of the present study was to observe the effects of S. melongena on the serum cholesterol and triglycerides of 38 hypercholesterolemic human volunteers ingesting S. melongena infusion for five weeks. Thirty-eight hypercholesterolemic subjects receiving either S. melongena infusion (N = 19) or placebo (N = 19) participated in two clinical experiments in which the effect of S. melongena infusion was studied with (N = 16) or without (N = 38) dietary orientation. Total cholesterol and its fractions, triglycerides, and apolipoproteins A and B were measured in blood at the beginning of the experiment and three and five weeks thereafter. No differences were observed compared to control. Intraindividual analysis showed that S. melongena infusion significantly reduced the blood levels of total and LDL cholesterol and of apolipoprotein B. After dietary orientation, no intra- or intergroup differences were seen for any of the parameters analyzed. The results suggest that S. melongena infusion had a modest and transitory effect, which was not different from that obtained with standard orientation for dyslipidemia patients (diet and physical activities).

Urinary nickel as bioindicator of workers' Ni exposure in a galvanizing plant in Brazil

OBJECTIVES

We measured urinary nickel (U-Ni) in ten workers (97 samples) from a galvanizing plant that uses nickel sulfate, and in ten control subjects (55 samples) to examine the association between occupational exposure to airborne Ni and Ni absorption.

METHODS

Samples from the exposed group were taken before and after the work shift on 5 successive workdays. At the same time airborne Ni (A-Ni) was measured using personal samplers. Ni levels in biological material and in the airborne were determined by a graphite furnace atomic absorption spectrometry validated method. In the control group the urine samples were collected twice a day, in the before and after the work shift, on 3 successive days.

RESULTS

Ni exposure low to moderate was detected in all the examined places in the plant, the airborne levels varying between 2.8 and 116.7 micrograms/m3 and the urine levels, from samples taken postshift, between 4.5 and 43.2 micrograms/g creatinine (mean 14.7 micrograms/g creatinine). Significant differences in U-Ni creatinine were seen between the exposed and control groups (Student's t test, P < or = 0.01). A significant correlation between U-Ni and A-Ni (r = 0.96; P < or = 0.001) was detected. No statistical difference was observed in U-Ni collected from exposed workers in the 5 successive days, but significant difference was observed between pre- and postshift samples.

CONCLUSIONS

Urinary nickel may be used as a reliable internal dose bioindicator in biological monitoring of workers exposed to Ni sulfate in galvanizing plants regardless of the day of the workweek on which the samples are collected.

Influence of bonded amalgam restorations on the fracture strength of teeth

This study evaluated the effect of bonded amalgam on the fracture strength of teeth using five adhesive systems: Panavia 21, Amalgambond Plus, Imperva Dual Bond, All-Bond 2 Primer/Bonding Resin, and All-Bond 2 Primer/Liner F. Intact teeth and amalgam lined with Copalite were used as control groups. Large MOD preparations were made in 20 extracted maxillary premolars for each group. The teeth were restored with Tytin. All groups were stored in water at 37 degrees C for 15 days and thermocycled 2500 times, over 8-48 degrees C. The specimens were preloaded five times in compression to 10 kg using a 5 mm-in-diameter, cylindrical steel indenter that contacted the teeth only on the cuspal inclines. Then the teeth were loaded to failure at 5.0 mm/min. The failure mode was recorded (amalgam failure, cusp fracture, or failure at the tooth/amalgam interface). The mean fracture strengths were analyzed using ANOVA and Newman-Keuls multiple comparisons. The Imperva Dual Bond group showed the highest mean forces followed by All-Bond 2 Primer/Bonding Resin. The All-Bond 2 Primer/Liner F and Amalgambond Plus groups demonstrated lower means and were not significantly different from the Copalite group. The Panavia 21 group was in between these two groups and was not statistically different from either group. The mean strength of intact teeth was the highest, but its very large coefficient of variation (60%) prevented effective use of these data for statistical comparison. Analysis of the mode of fracture showed that Panavia 21, All-Bond 2 Primer/Bonding Resin, and Amalgambond Plus failed cohesively in the amalgam in 35%, 25%, and 15% of the specimens respectively. This fracture type is a good indication of effective bonding between tooth and amalgam. The most common type of fracture for all the restored groups was the one that occurred at the tooth/restoration interface. This would suggest that current bonding procedures could be improved.

[The risk of diabetes mellitus in relatives of diabetics treated with insulin]

The objective of this study was to compare the risk of diabetes mellitus in the relatives of type 1 (defined as cases diagnosed before 40 years and beginning insulin less than two years later) and in those of type 2 diabetics, treated with insulin. A random sample of 303 patients was obtained from responders to a postal survey sent to all 2800 diabetics living in the Oporto self county and identified as users of insulin the injection pen. After selecting those who completed the questions for sex, age, dates of diabetes diagnosis and of first insulin prescription, we were left with 192 index cases. They provided data concerning sex; age, and presence of diabetes for 1370 relatives (parents, siblings, offspring and spouses). The risk of diabetes (unspecified type) in family members was significantly lower in relatives of type 1 diabetics (OR = 0.31, CI 95%:0.19-0.48, p < 0.0005). This family risk was lower when the index case was a male (OR = 0.24, CI 95%:0.12-0.47 vs OR = 0.39, CI 95%:0.21-0.74) or for female relatives (OR = 0.22, CI 95%:0.11-0.42 vs OR = 0.43, CI 95%:0.22.-0.82). After adjustment for confounders applying logistic regression to each family stratum, the risk remained significantly lower for parents (OR = 0.35, CI 95%:0.17-0.71) and siblings of type 1 diabetics compared to similar relatives of type 2 cases (OR = 0.84, CI 95%:0.06-10.6) but was not significantly different for the offspring (OR = 0.68, CI 95%:0.11-4.17) or the spouses (OR = 0.84, CI 95%:0.06-10.6).(ABSTRACT TRUNCATED AT 250 WORDS)

Gene dosage evidence for the regional assignment of GPT (glutamate-pyruvate transaminase; E.C. 2.6.1.2) locus to 8q24.2----8qter

The results of a study on the expression of GPT (glutamate-pyruvate transaminase; E.C. 2.6.1.2) in a child with a partial trisomy of chromosomes 8 and 14 are presented. A gene dosage effect supporting the regional assignment of the GPT locus to 8q24.2----8qter is demonstrated.